Erratum to: Goulart et al. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw 2012;10(2):267–275.

The February 2012 article by Goulart et al titled, “Lung Cancer Screening With Low-Dose Computed Tomography: Costs, National Expenditures, and Cost-Effectiveness,” (J Natl Compr Canc Netw 2012, doi: 10.6004/jnccn.2012.0023) was published with an error.

On page 267, in the last sentence in the right-hand column, a percentage given as a “high false-positive screening rate” from the National Lung Screening Trial (NLST) was actually a “high false discovery rate” in the NLST study. Thus, the sentence should have read: “The main concerns include the financial burden that a national [low-dose chest CT] screening program would imposed on the U.S. health care system, which currently struggles to contain escalating expenditures, and the patient burden that results from a high false discovery screening rate (estimated as 96.4% in the NCLS), including unnecessary costs and harms cause by additional imaging tests and surgical procedures.”

The journal apologizes for the error.

If the inline PDF is not rendering correctly, you can download the PDF file here.


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 107 107 37
PDF Downloads 13 13 3
EPUB Downloads 0 0 0